These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 37954653)
1. MicroRNA-21 Contributes to Cutaneous Squamous Cell Carcinoma Progression via Mediating TIMP3/PI3K/AKT Signaling Axis [Retraction]. Int J Gen Med; 2023; 16():5159-5160. PubMed ID: 37954653 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-21 Contributes to Cutaneous Squamous Cell Carcinoma Progression via Mediating TIMP3/PI3K/AKT Signaling Axis. Yin S; Lin X Int J Gen Med; 2021; 14():27-39. PubMed ID: 33447074 [TBL] [Abstract][Full Text] [Related]
3. [Retracted] MicroRNA‑451a prevents cutaneous squamous cell carcinoma progression via the 3‑phosphoinositide‑dependent protein kinase‑1‑mediated PI3K/AKT signaling pathway. Fu J; Zhao J; Zhang H; Fan X; Geng W; Qiao S Exp Ther Med; 2024 Jul; 28(1):280. PubMed ID: 38800047 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of microRNA-15b-5p Attenuates the Progression of Oral Squamous Cell Carcinoma via Modulating the Cancer Manag Res; 2023; 15():981-982. PubMed ID: 37693220 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling. Si F; Sun J; Wang C Exp Ther Med; 2021 Oct; 22(4):1090. PubMed ID: 34504544 [TBL] [Abstract][Full Text] [Related]
6. Retraction: ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway. Yin H; Wang L; Li F; Wang D; Zhang Z; Yu B; Liu Y Transl Cancer Res; 2023 Nov; 12(11):3222. PubMed ID: 38130303 [TBL] [Abstract][Full Text] [Related]
7. Retraction Notice to: Tumor-Suppressive MicroRNA-216b Binds to TPX2, Activating the p53 Signaling in Human Cutaneous Squamous Cell Carcinoma. Feng C; Zhang HL; Zeng A; Bai M; Wang XJ Mol Ther Nucleic Acids; 2022 Jun; 28():638. PubMed ID: 35615003 [TBL] [Abstract][Full Text] [Related]
8. microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction]. Cancer Manag Res; 2021; 13():4765. PubMed ID: 34163251 [TBL] [Abstract][Full Text] [Related]
13. Retraction notice for: "Suppressive effect of platycodin D on bladder cancer through microRNA-129-5p-mediated PABPC1/PI3K/AKT axis inactivation" [Braz J Med Biol Res 2021;54(3): e10222]. Braz J Med Biol Res; 2022 Aug; 55():e10222retraction. PubMed ID: 35976272 [TBL] [Abstract][Full Text] [Related]
14. microRNA-26a Directly Targeting MMP14 and MMP16 Inhibits the Cancer Cell Proliferation, Migration and Invasion in Cutaneous Squamous Cell Carcinoma [Retraction]. Cancer Manag Res; 2021; 13():7249-7250. PubMed ID: 34566433 [TBL] [Abstract][Full Text] [Related]
15. Loss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma [Retraction]. Onco Targets Ther; 2023; 16():801-802. PubMed ID: 37794861 [TBL] [Abstract][Full Text] [Related]
16. [Retracted] Knockdown of circ_0001883 may inhibit epithelial‑mesenchymal transition in laryngeal squamous cell carcinoma via the miR‑125‑5p/PI3K/AKT axis. Chen F; Lao Z; Zhang H; Wang J; Wang S Exp Ther Med; 2024 Apr; 27(4):129. PubMed ID: 38414792 [TBL] [Abstract][Full Text] [Related]
17. Retraction: Long non-coding RNA NEAT1 accelerates cell progression in cervical cancer by regulating the miR-889-3p/E2F7 axis through the activation of the PI3K/AKT pathway. Fisher L RSC Adv; 2021 Jan; 11(9):5025. PubMed ID: 35426981 [TBL] [Abstract][Full Text] [Related]
18. The KMT1A/TIMP3/PI3K/AKT circuit regulates tumor growth in cervical cancer. Yang D; Fan L; Song Z; Fang S; Huang M; Chen P Reprod Biol; 2022 Sep; 22(3):100644. PubMed ID: 35661980 [TBL] [Abstract][Full Text] [Related]